Search

Search Results

• 

  Genetic predictors of response to anti-tumor necrosis factor drugs in rheumatoid arthritis

  Rachael Joo Lee Tan, Anne Barton

  e1

  03-06-2009

  https://doi.org/10.4081/rr.2009.e1

  17602

  PDF: 509

  HTML: 9265
• 

  Successful treatment of neuro-Behçet’s disease with infliximab: four years follow-up

  Manjinder Kaur, Emily S. Nia, Rebecca A. Millius, Dominick G. Sudano, Jeffrey R. Lisse

  20-10-2015

  https://doi.org/10.4081/rr.2015.6115

  1911

  PDF: 746
• 

  The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting

  Martin A. Lee, Stuart Kyle, Robert J. Moots

  e2

  26-03-2012

  https://doi.org/10.4081/rr.2012.e2

  1246

  PDF: 446
• 

  Behçet’s disease: an update on pathogenesis, diagnosis and management of vascular involvement

  Phaedon G. Kaklamanis, Kenneth T. Calamia

  e2

  15-03-2010

  https://doi.org/10.4081/rr.2010.e2

  2447

  PDF: 832

  HTML: 2276
• 

  Biomarkers of outcome in rheumatoid arthritis

  Roberto Carrasco, Anne Barton

  e3

  02-09-2010

  https://doi.org/10.4081/rr.2010.e3

  7638

  PDF: 906

  HTML: 21694
• 

  Multicentric reticulohistiocytosis: an example of the value of skin biopsy in joint disease

  Ruth Smith, Chris Stonard, Rengi Mathew

  13-10-2015

  https://doi.org/10.4081/rr.2015.5832

  1208

  PDF: 716
• 

  A case of relapsing polychondritis mimicking Ludwig’s angina

  Adnan Agha, Hussain Asiri, Ali Shehri, Abdelhaleem Bella, Mohamed Bazeed

  e6

  10-09-2009

  https://doi.org/10.4081/rr.2009.e6

  1610

  PDF: 703

  HTML: 21083
• 

  Iguratimod (T-614): A novel disease modifying anti-rheumatic drug

  Keiichi Tanaka

  e4

  23-07-2009

  https://doi.org/10.4081/rr.2009.e4

  5007

  PDF: 1337

  HTML: 35015